Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate

Charles Craddock; Charlotte Bradbury; S Narayanan; A Rye; Supratik Basu; A MacWhannell; A Sawers; M Cook; M Griffiths; D Grimwade; Christopher Bunce; B Turner

Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate

Charles Craddock, Charlotte Bradbury, S Narayanan, A Rye, Supratik Basu, A MacWhannell, A Sawers, M Cook, M Griffiths, D Grimwade, Christopher Bunce, B Turner

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Pages	783A
Publication status	Published - 1 Jan 2005

Cite this

@conference{b8853f20415d4194bf49e673388d61e8,

title = "Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate",

author = "Charles Craddock and Charlotte Bradbury and S Narayanan and A Rye and Supratik Basu and A MacWhannell and A Sawers and M Cook and M Griffiths and D Grimwade and Christopher Bunce and B Turner",

year = "2005",

month = jan,

day = "1",

language = "English",

pages = "783A",

}

TY - CONF

T1 - Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate

AU - Craddock, Charles

AU - Bradbury, Charlotte

AU - Narayanan, S

AU - Rye, A

AU - Basu, Supratik

AU - MacWhannell, A

AU - Sawers, A

AU - Cook, M

AU - Griffiths, M

AU - Grimwade, D

AU - Bunce, Christopher

AU - Turner, B

PY - 2005/1/1

Y1 - 2005/1/1

M3 - Abstract

SP - 783A

ER -